Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
Status:
Completed
Trial end date:
2016-07-29
Target enrollment:
Participant gender:
Summary
To collect retrospectively the efficacy and safety information of azithromycin IV on patients
with Legionnaires' disease related to their appropriate use in daily practice.